[Hypertensive nephrosclerosis].
Krummel T, Bazin D, Faller AL, Hannedouche T.
Presse Med. 2012 Feb;41(2):116-24. doi: 10.1016/j.lpm.2011.04.008. Epub 2011 Jun 8.
Proteinuria and hypertension.
Ritz E, Nowicki M, Fliser D, Hörner D, Klimm HP.
Kidney Int Suppl. 1994 Nov;47:S76-80.
"Benign" hypertensive nephrosclerosis.
Dasgupta I, Porter C, Innes A, Burden R.
QJM. 2007 Feb;100(2):113-9. doi: 10.1093/qjmed/hcl139. Epub 2007 Jan 23.
Nephrosclerosis and hypertension.
Ono H, Ono Y.
Med Clin North Am. 1997 Nov;81(6):1273-88. doi: 10.1016/s0025-7125(05)70582-4.
Effect of Proteinuria and Glomerular Filtration Rate on Renal Outcome in Patients with Biopsy-Proven Benign Nephrosclerosis.
Sumida K, Hoshino J, Ueno T, Mise K, Hayami N, Suwabe T, Kawada M, Imafuku A, Hiramatsu R, Hasegawa E, Yamanouchi M, Sawa N, Fujii T, Ohashi K, Takaichi K, Ubara Y.
PLoS One. 2016 Jan 25;11(1):e0147690. doi: 10.1371/journal.pone.0147690. eCollection 2016.
Time-averaged proteinuria during follow-up and renal prognosis in patients with biopsy-proven benign nephrosclerosis.
Amano H, Koike K, Haruhara K, Tsuboi N, Ogura M, Yokoo T.
Clin Exp Nephrol. 2020 Aug;24(8):688-695. doi: 10.1007/s10157-020-01885-w. Epub 2020 Apr 9.
Progression of renal failure -- the role of hypertension.
Whitworth JA.
Ann Acad Med Singap. 2005 Jan;34(1):8-15.
Malignant or accelerated hypertension.
Vaziri ND.
West J Med. 1984 Apr;140(4):575-82.
[Benign nephrosclerosis and malignant nephrosclerosis].
Kohagura K, Ohya Y.
Nihon Jinzo Gakkai Shi. 2016;58(2):85-91.
Renal ablation acutely transforms 'benign' hypertension to 'malignant' nephrosclerosis in hypertensive rats.
Bidani AK, Griffin KA, Plott W, Schwartz MM.
Hypertension. 1994 Sep;24(3):309-16. doi: 10.1161/01.hyp.24.3.309.
